Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate
Sardu C, Paolisso P, Sacra C et al.

KEYWORDS
cardiac resynchronization therapy with defibrillator; diabetes mellitus; arrhythmic burden; heart failure